TGA Proposes Stronger Vitamin B6 Labeling for Low-Risk Medicines
Audio narration · Coming soon
The Therapeutic Goods Administration (TGA) has initiated a public consultation to gather feedback on its proposal to enhance labeling requirements for vitamin B6 in low-risk medicines. This move aims to improve consumer information and safety regarding vitamin B6 content in these products.
Why this matters
PRISM scored this story 45/100 for interest.
Originally published by gnews